Venus Remedies gets marketing approval for oncology medicines from Philippines, Iraq
Venus Remedies also expects marketing authorisation from Iraq for another commonly prescribed cancer drug, gemcitabine, to enhance…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
oncology
AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer
The approval for AstraZeneca molecule is based on the findings of TOPAZ-1, a Phase-3 global clinical trial with patients recruited…
University of East Anglia researchers make a breakthrough for ‘next gen’ cancer treatment
The treatment would work by switching on LED lights embedded close to a tumour, which would then activate biotherapeutic drugs
Sanofi and IGM Biosciences announce collaboration agreement for oncology, immunology and…
Collaboration to create, develop, manufacture and commercialise new class of potential therapeutics combining the superior…
2021 is a key year for personalised neoantigen immuno-oncology therapeutics: GlobalData
The four molecules expected to launch first, autogene cevumeran, GRANITE-001, ATL001, and Genocea Biosciences’ GEN-009 have…
Patient access to gene therapies for cancer likely to increase in the next decade: GlobalData
These therapies are expected to eliminate the need for further treatments and reduce the cost of disease management
Bayer and Zydus extend their JV for three years
The joint venture will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and…
Key unmet needs in HNSCC may be partly addressed by clinical development in next decade: GlobalData
The next decade may see the introduction of personalised therapy options in locally advanced HNSCC settings along with…
Pancreatic cancer market to reach $4.1 billion by 2029: GlobalData
Growth in pancreatic cancer therapy market will be driven by the introduction of drugs with novel mechanisms of action, across…
CRISPR-based cancer therapies likely to be a disruptive technology in healthcare: GlobalData
Three leading companies racing to bring CRISPR therapies to the clinic are CRISPR Therapeutics, Intellia Therapeutics and Editas…